Machine Learning

S2G Energy and AMPECO power one of LATAM's largest EV fleets, using advanced software to slash costs and create a blueprint for sustainable logistics.

A new pilot program uses AI to find hidden patterns in past cancer trial data, aiming to get the right drugs to the right patients, faster.

With strong revenue, key AI upgrades, and a top Microsoft award, Blue Yonder is solidifying its market lead as global supply chain pressures intensify.

After a year away, ENGWE is back in the U.S. with a beastly new e-bike. Can the M20 3.0's monster specs overcome past issues and a crowded market?

A new 'zero-disruption' plate from TheWell Bioscience aims to solve key challenges in organoid research, promising more reliable data for drug discovery.

A new PropTech startup is using a memorable phone number and advanced AI to bypass Zillow, promising cheaper, more accurate home valuations for everyone.

A new AI platform called Kind puts users in control, generating accurate answers only from your personal data and promising to never make things up.

Backed by a proven billion-dollar impact model, 14 new startups are using AI, neuroscience, and philanthropy to revolutionize mental healthcare.

A new initiative backed by the Japanese government aims to transform the nation's world-class scientific research into globally competitive biotech companies.

A Chinese biotech's novel nasal spray flu vaccine enters trials. Its unique design could finally make it safe for the elderly and expand global access.

A landmark deal will see Takeda use Iambic's AI platform to slash drug development timelines and fast-track new medicines for cancer and other diseases.

Guardforce AI aims to acquire a leading speech therapy platform, signaling a major strategic pivot from secured logistics to the booming AI healthcare market.

From its unique seat at the World Government Summit, CanSinoBIO unveils its next-gen vaccine pipeline and global strategy to fight humanity's oldest diseases.

With five conferences in its sights, Voyager Therapeutics is making a major push to win over investors ahead of a pivotal year for its neurological pipeline.

A £500,000 philanthropic investment fuels five pioneering research projects at Oxford, aiming to unlock new treatments for a devastating rare disease.

With a new flexible, founder-first model, Activation Capital's Frontier BioHealth program aims to bridge the commercialization gap for life sciences startups.

IN8bio promotes Kate Rochlin to President, signaling a strategic push to advance its promising gamma-delta T cell pipeline amid a challenging market.

With a promising spinal cord injury drug nearing late-stage trials, NervGen appoints interim leader Dr. Adam Rogers as permanent CEO to guide the breakthrough.

Semiconductor leader Astera Labs launches a new R&D hub in Israel, hiring top tech veterans to develop next-gen connectivity for the demanding AI era.

Emerging from stealth with Fortune 500 clients, Freehand's autonomous AI agents promise to end manual work in procurement and finance.